BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4752126)

  • 1. Sodium cyanate: chemical properties relevant to sickle cell disease therapy.
    Labbe RF
    J Pharm Sci; 1973 Oct; 62(10):1727-9. PubMed ID: 4752126
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the blood concentrations of cyanate after intravenous administration to patients with sickle-cell disease.
    Nigen AM; Peterson CM; Gillette PN; Manning JM
    J Lab Clin Med; 1974 Jan; 83(1):139-46. PubMed ID: 4808651
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium cyanate as a potential treatment for sickle-cell disease.
    Gillette PN; Peterson CM; Lu YS; Cerami A
    N Engl J Med; 1974 Mar; 290(12):654-60. PubMed ID: 4813727
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical use of cyanate in sickling.
    Ranney HM
    N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186
    [No Abstract]   [Full Text] [Related]  

  • 5. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM; Lee CK; Cerami A; Gillette PN
    J Lab Clin Med; 1973 Jun; 81(6):941-5. PubMed ID: 4710373
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP; Grever MR; Sing DE; Bishop JN; Segal ML
    J Lab Clin Med; 1982 Sep; 100(3):345-55. PubMed ID: 7108349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of sickle cell disease: an approach with sodium cyanate.
    Peterson CM; Cerami A
    Semin Hematol; 1974 Oct; 11(4):569-76. PubMed ID: 4213637
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanate-induced cataracts in patients with sickle-cell hemoglobinopathies.
    Nicholson DH; Harkness DR; Benson WE; Peterson CM
    Arch Ophthalmol; 1976 Jun; 94(6):927-30. PubMed ID: 938283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Toxicity of sodium cyanate.
    Charache S
    N Engl J Med; 1974 Jul; 291(4):212. PubMed ID: 4834501
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyanate effect on sickling.
    Charache S; Milner PF
    N Engl J Med; 1972 Dec; 287(26):1357-8. PubMed ID: 4635027
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of sodium cyanate in patients with sickle cell disease and the lack of inhibition in vitro of globin synthesis at in vivo concentrations of cyanate.
    Nigen AM; Manning JM; Peterson CM; White JM
    J Pharmacol Exp Ther; 1975 Nov; 195(2):333-9. PubMed ID: 1185602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with intravenous sodium cyanate in patients with sickle cell anemia.
    Peterson CM; Lu YS; Herbert JT; Cerami A; Gillette PN
    J Pharmacol Exp Ther; 1974 Jun; 189(3):577-84. PubMed ID: 4602044
    [No Abstract]   [Full Text] [Related]  

  • 15. Urea, cyanate and sickling.
    Harris A
    N Engl J Med; 1971 Sep; 285(12):690-1. PubMed ID: 5563487
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyanate and sickling.
    Charache S; Diederich D
    N Engl J Med; 1971 Nov; 285(20):1147. PubMed ID: 5095746
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of cyanate with a summary of its initial usage in sickle cell disease.
    Gillette PN; Lu YS; Peterson CM
    Prog Hematol; 1973; 8():181-90. PubMed ID: 4788375
    [No Abstract]   [Full Text] [Related]  

  • 18. Sickling, urea and cyanate.
    Nalbandian RM
    N Engl J Med; 1972 Feb; 286(7):378-9. PubMed ID: 5008568
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cyanate on red blood cell sickling.
    Cerami A; Manning JM; Gillette PN; De Furia F; Miller D; Graziano JH; Peterson CM
    Fed Proc; 1973 Jun; 32(6):1668-72. PubMed ID: 4268029
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium cyanate induced polyneuropathy in patients with sickle-cell disease.
    Peterson CM; Tsairis P; Onishi A; Lu YS; Grady R
    Ann Intern Med; 1974 Aug; 81(2):152-8. PubMed ID: 4843571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.